|
NCCN Guidelines® Insights - Prostate Cancer, Version 3.2024 |
1.00 |
04/10/2024 - 12:00am to 04/10/2025 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Oncology Stewardship: Best Practices for Pharmacists in Optimizing Patient Safety and Quality... |
1.00 |
05/02/2024 - 12:00am to 05/02/2025 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Systemic Therapy for Metastatic Prostate Cancer |
1.00 |
05/02/2024 - 12:00am to 05/02/2025 - 12:00am |
|
NCCN Pharmacy Updates: Management of Immunotherapy-Associated Oral Toxicities |
1.00 |
05/08/2024 - 12:00am to 08/31/2024 - 12:00am |
|
NCCN Guidelines® Insights - Bladder Cancer, Version 3.2024 |
1.00 |
05/10/2024 - 12:00am to 05/10/2025 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma |
1.00 |
05/17/2024 - 12:00am to 05/17/2025 - 12:00am |
|
NCCN Pharmacy Updates: Hematopoietic Cell Transplantation - An Overview of Hematopoietic Cell Mobilization |
1.00 |
05/28/2024 - 12:00am to 10/13/2024 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: Updates in Treatment of Hairy Cell Leukemia |
1.00 |
05/29/2024 - 12:00am to 05/29/2025 - 12:00am |
|
NCCN Pharmacy Updates: Navigating the Challenging Treatment Landscape for HIV-Associated, Non-AIDS Defining Cancers |
1.00 |
05/31/2024 - 12:00am to 11/01/2024 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: Updates in Ovarian Cancer - Putting Together the PARP Puzzle and Understanding a New... |
1.00 |
06/04/2024 - 12:00am to 06/04/2025 - 12:00am |
|
NCCN Pharmacy Updates: What Grade Are You In? The Role of Targeted Therapy in Pediatric Diffuse High-Grade Gliomas |
1.00 |
06/05/2024 - 12:00am to 12/01/2024 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas |
1.00 |
06/05/2024 - 12:00am to 06/05/2025 - 12:00am |
Facebook
Twitter
LinkedIn
Forward